The pandemic has shifted the politics and public opinion on health care. Where cost was a primary concern before COVID, now access to affordable innovations is top of consumers’ and policy makers’ minds. As a return to normalcy appears on the horizon, the intersection of cost pressures and innovation in pharmacy is becoming a primary topic of concern in health policy.
State of Reform is looking forward to exploring this topic in depth at our upcoming “5 Slides: Bending the Rx cost curve” virtual convening. The conversation will take place on Thursday, January 20, from 1:00 – 2:00pm Eastern Time.
In this discussion, health experts will offer insight into innovative strategies to reduce costs which could include formulary adjustments, strategies to increase the use of biosimilars, or other creative policy solutions.
The conversation will bring together Robert Popovian, PharmD, senior health policy fellow at the Progressive Policy Institute, Andrea Reed, vice president of pharmacy at Novant Health, and Annette Guarisco Fildes, president & CEO of The ERISA Industry Committee.
Each panelist will offer one slide highlighting a key question or topic they think is worth discussing. This event is free to attend, but you have to register to join us. You’ll be able to pose questions and participate in the conversation as well, just as you do at our conferences.